Skip to content
zameds

Atropine, hyoscine, hyoscyamine, phenobarbitone

Sold as Bellavern, Millerspas, Bellatard

Every registration of this product has been cancelled.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
2
Registrations
3

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
The Premier Pharmaceutical Co LtdCancelledBellavern, BellatardNot statedB1282, E1981Not determinedNone
Pharmacare limited û woodmeadCancelledMillerspasNot statedE0577Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Bellavern

TABLET ATROPINE SULPHATE A 20 UG HYOSCINE HYDROBROMIDE A 6UG HYOSCYAMINE SULPHATE A 0,104 MG PHENOBARBITONE A 15 MG

Not listedB1282CancelledNot determinedNone
Millerspas

EACH TABLET CONTAINS ATROPINE SULPHATE A 0,02 MG HYOSCINE HYDROBROMIDE A 0,006 MG HYOSCYAMINE SULPHATE A 0,104 MG PHENOBARBITONE A 15 MG

Not listedE0577CancelledNot determinedNone
Bellatard

CAPSULE ATROPINE SULPHATE A 0,058 MG HYOSCINE HYDROBROMIDE A 0,019 MG HYOSCYAMINE SULPHATE A 0,311 MG PHENOBARBITONE A 50 MG

Not listedE1981CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles